CM, expanding its market reach. JP Morgan upgrades the stock, projecting strong sales and a multi-billion opportunity.

Mirum Pharmaceuticals stock surged 25% and how LIVMARLI drives growth. Explore future prospects with Volixibat. Click here to ...

Benchmark indices Nifty and Sensex traded marginally higher on March 25, thanks to support provided by IT stocks. However, ...

The Hang Seng Index is under consolidation as traders await development on the US tariffs front, says analyst Kenny Wen.

We recently published a list of the 12 Best Diagnostics Stocks to Invest In Right Now. In this article, we are going to take ...

Pfizer's stock has recently struggled but remains a bargain with generous dividends. Is now a good time to invest in PFE?

We recently published a list of the 12 Best Diagnostics Stocks to Invest In Right Now. In this article, we are going to take ...

The Phase 2b ASPIRE clinical trial of intravitreal UBX1325 involed patients with diabetic macular edema (DME) who had poor ...

Amid this market rebound, numerous mid-cap and small-cap mutual funds have demonstrated impressive gains, with five funds ...

Investors’ main focus now is the US tariff deadline on April 2nd, when president Trump is expected to announce widespread ...

Financial experts have set an average price target of €9.68 for Evotec shares, suggesting significant upward potential from current levels. This optimism persists despite projected losses for the full ...

Advisors Asset Management Inc. trimmed its stake in Regeneron Pharmaceuticals by 7.9%, selling 443 shares in the fourth ...